Cargando…
Hierarchically tumor-activated nanoCRISPR-Cas13a facilitates efficient microRNA disruption for multi-pathway-mediated tumor suppression
Rationale: CRISPR-Cas13a is an efficient tool for robust RNA knockdown with lower off-target effect, which may be a potentially powerful and safe tool for cancer gene therapy. However, therapeutic effect of current cancer gene therapy that targeting monogene was compromised by the multi-mutational s...
Autores principales: | Liu, Xiaowei, Yang, Suleixin, Wang, Li, Wu, Xinyue, Wang, Xinxin, Ou, Chunqing, Yang, Jin, Song, Linjiang, Zhou, Shiyao, Wu, Qinjie, Gong, Changyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240819/ https://www.ncbi.nlm.nih.gov/pubmed/37284454 http://dx.doi.org/10.7150/thno.81776 |
Ejemplares similares
-
A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer
por: Liu, Chao, et al.
Publicado: (2021) -
Photoactivatable nanoCRISPR/Cas9 System Based on crRNA Reversibly Immobilized on Carbon Nanoparticles
por: Semikolenova, Olga, et al.
Publicado: (2021) -
Novel polyethyleneimine-R8-heparin nanogel for high-efficiency gene delivery in vitro and in vivo
por: Song, Linjiang, et al.
Publicado: (2017) -
An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy
por: Li, Ling, et al.
Publicado: (2018) -
Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo
por: Wang, Ning, et al.
Publicado: (2017)